Co-Administration of Rivaroxaban With Drugs That Share Its Elimination Pathways: Pharmacokinetic Effects in Healthy Subjects

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12075
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects

Drugs in R and D
Pharmacology
2011English

Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects

Clinical Pharmacokinetics
Pharmacology
2009English

Pharmacokinetic Study of Frusemide in Healthy and Cirrhotic Indian Subjects

Internet Journal of Medical Update
Medicine
2008English

Population Pharmacokinetic Modeling and Simulation of Fremanezumab in Healthy Subjects and Patients With Migraine

British Journal of Clinical Pharmacology
Pharmacology
2019English

Mechanistic Pharmacokinetic Modelling of Ephedrine, Norephedrine and Caffeine in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2005English

Clinical Pharmacokinetic Studies of Disopyramide Following Single Oral Administration of Disopyramide to Healthy Subjects and Patients Suffering Arrhythmia.

Japanese Journal of Hospital Pharmacy
1993English

Population Pharmacokinetic Analysis of Cilostazol in Healthy Subjects With Genetic Polymorphisms of CYP3A5, CYP2C19 andABCB1

British Journal of Clinical Pharmacology
Pharmacology
2010English

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2017English

Effects of Abdominal Hot Compresses on Indocyanine Green Elimination – A Randomized Cross Over Study in Healthy Subjects

BMC Gastroenterology
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy